Table 2 Characteristics of the study participants at baseline (N = 119)
From: A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae
Characteristics | Mild (n = 58) | Moderate (n = 30) | Severe (n = 31) |
|---|---|---|---|
Age, mean (SD), y | 39.2 (15.9) | 62.1 (14) | 59.7 (13.3) |
Sex, no. (%) | |||
 Female | 42 (71) | 15 (52) | 9 (29) |
 Male | 16 (29) | 15 (48) | 22 (71) |
BMIa, mean (SD) | 26.3 (5.3) | 36.5 (7.5) | 36.5 (10.7) |
Ethnicity, no. (%) | |||
 Non-Hispanic/Latinx | 54 (93) | 23 (76.6) | 18 (58) |
 Hispanic/Latinx | 4 (7) | 7 (23.4) | 13 (42) |
Co-existing conditions, no. (%) | |||
 CVA | 0 | 3 (11) | 1 (3.2) |
 COPD | 1 (2) | 5 (18.5) | 3 (9.7) |
 DM | 1 (2) | 8 (26) | 16 (48.4) |
 HTN | 1 (2) | 11 (40) | 19 (57.6) |
 CAD | 1 (2) | 2 (7.4) | 1 (3.2) |
 Active cancer | 0 | 3 (11) | 0 |